A small 2024 study found no semaglutide in breast milk samples, and a 2026 study found little to no tirzepatide
Consequently, it has improved potency and metabolic stability [5]
But they started responding to GLP-1 microdosing in ways that were hard to ignore
This case is notable because the patient had previously tolerated dulaglutide without any injection site reactions, emphasizing that tolerance to one GLP-1 agonist does not predict tolerance to another
Phillips, Winter Park, Lake Nona, or downtown Orlando, access to FDA-approved weight loss treatments like Wegovy, Ozempic, and Rybelsus is changing lives across Central Florida
This is where GLP-1 medications can be particularly valuable tools